Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
S340911-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $49.90 | |
S340911-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $135.90 | |
S340911-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $229.90 |
an imidazopyrimidine inhibitor of Syk and Syk-mediated functions
Synonyms | Kinome_3125 | BAY-61-360 | UNII-61G8S0H9KX | BAY 61-3606 free base | CCG-102604 | AT32059 | BAY-61-3606 free base | DTXSID101017352 | HMS3295M09 | NCGC00346945-06 | AC-29888 | J-507625 | NCGC00346945-01 | CS-0235 | 2-hydroxy-isonicotinic acid methyl ester |
---|---|
Specifications & Purity | Moligand™, ≥97% |
Storage Temp | Store at 2-8°C |
Shipped In | Wet ice |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of component of inhibitor of nuclear factor kappa B kinase complex;Inhibitor of mitogen-activated protein kinase kinase kinase kinase 2;Inhibitor of spleen associated tyrosine kinase |
Product Description |
BAY 61-3606 (Syk inhibitor IV) is an active, ATP-competitive reversible selective Syk inhibitor. It acts on breast cancer cells and promotes TRAIL-induced apoptosis by down-regulating Mcl-1. It reduces ERK1/2 and Akt phosphorylation in neuroblastoma cells, as well as Syk phosphorylation in K-rn cell lysates
|
Ki Data | Syk tyrosine kinase activity: Ki= 7.5 nM |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 2-[[7-(3,4-dimethoxyphenyl)imidazo[1,2-c]pyrimidin-5-yl]amino]pyridine-3-carboxamide |
---|---|
INCHI | InChI=1S/C20H18N6O3/c1-28-15-6-5-12(10-16(15)29-2)14-11-17-22-8-9-26(17)20(24-14)25-19-13(18(21)27)4-3-7-23-19/h3-11H,1-2H3,(H2,21,27)(H,23,24,25) |
InChi Key | JWQOJVOKBAAAAR-UHFFFAOYSA-N |
Canonical SMILES | COC1=C(C=C(C=C1)C2=CC3=NC=CN3C(=N2)NC4=C(C=CC=N4)C(=O)N)OC |
Isomeric SMILES | COC1=C(C=C(C=C1)C2=CC3=NC=CN3C(=N2)NC4=C(C=CC=N4)C(=O)N)OC |
Alternate CAS | 732983-37-8 |
PubChem CID | 10200390 |
MeSH Entry Terms | 2-(7-(3,4-dimethoxyphenyl)imidazo(1,2-c)pyrimidin-5-ylamino)nicotinamide;BAY 61-3606;BAY-61-3606;BAY61-3606 |
Molecular Weight | 390.40 |
Enter Lot Number to search for COA:
Solubility | Soluble in DMSO (10 mg/ml), water (20 mg/ml), and methanol. |
---|
Starting at $128.90
Starting at $264.90
Starting at $73.90
1. Yamamoto N, Takeshita K, Shichijo M, Kokubo T, Sato M, Nakashima K, Ishimori M, Nagai H, Li YF, Yura T et al.. (2003) The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents.. J Pharmacol Exp Ther, 306 (3): (1174-81). [PMID:12766258] [10.1021/op500134e] |
2. Ho CM, Donovan-Banfield IZ, Tan L, Zhang T, Gray NS, Strang BL. (2016) Inhibition of IKKα by BAY61-3606 Reveals IKKα-Dependent Histone H3 Phosphorylation in Human Cytomegalovirus Infected Cells.. PLoS ONE, 11 (3): (e0150339). [PMID:26930276] [10.1021/op500134e] |